UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2015-07, Vol.18 (3), p.476-484

2015

Volltextzugriff (PDF)

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

The oncologist (Dayton, Ohio), 2021-03, Vol.26 (3), p.e394-e402

2021

Volltextzugriff (PDF)

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Clinical cancer research, 2014-01, Vol.20 (2), p.511-521

2014

Volltextzugriff (PDF)

Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues

Proteomics (Weinheim), 2014-03, Vol.14 (4-5), p.441-451

2014

Volltextzugriff (PDF)

Questioning behaviours and patterns of prospective teachers on practicum

Cogent education, 2020-01, Vol.7 (1)

2020

Volltextzugriff (PDF)

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice

Cancers, 2022-06, Vol.14 (12), p.2905

2022

Volltextzugriff (PDF)

Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody

Cancer chemotherapy and pharmacology, 2015-04, Vol.75 (4), p.837-850

2015

Volltextzugriff (PDF)

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe

Journal of personalized medicine, 2022-01, Vol.12 (1), p.72

2022

Volltextzugriff (PDF)

Critical Humanities and Ageing: Forging Interdisciplinary Dialogues

1, 2022

Volltextzugriff (PDF)

An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples

Journal of clinical bioinformatics, 2013-05, Vol.3 (1), p.10-10

2013

Volltextzugriff (PDF)

Die Bedeutung von Biobanken für die klinische Entwicklung

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2016-03, Vol.59 (3), p.344-350

2016

Volltextzugriff (PDF)

Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study

Lung cancer (Amsterdam, Netherlands), 2022-05, Vol.167, p.41-48

2022

Volltextzugriff (PDF)

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

Arthritis research & therapy, 2009-01, Vol.11 (2), p.R38-R38

2009

Volltextzugriff (PDF)

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view

European journal of cancer (1990), 2023-11, Vol.194, p.113278-113278, Article 113278

2023

Volltextzugriff (PDF)

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

The oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.e769-e779

2021

Volltextzugriff (PDF)

Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9592-9592

2020

Volltextzugriff (PDF)

Does Organized Crime Attract EU Funding? Evidence from Sicily

Thomas, Marlene

2021

Volltextzugriff (PDF)

Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

The Lancet (British edition), 2024-08, Vol.404 (10452), p.527-539

2024

Volltextzugriff (PDF)

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Cancer cell, 2023-11, Vol.41 (11), p.1963-1971.e3

2023

Volltextzugriff (PDF)

Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)[S]

Molecular & cellular proteomics, 2015-10, Vol.14 (10), p.2775-2785

2015

Volltextzugriff (PDF)

The significance of biobanks for clinical development

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2016-03, Vol.59 (3), p.344-350

2016

Volltextzugriff (PDF)

Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab

Cancer chemotherapy and pharmacology, 2017-06, Vol.79 (6), p.1239-1247

2017

Volltextzugriff (PDF)

Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

European journal of cancer (1990), 2019-06, Vol.114, p.128-136

2019

Volltextzugriff (PDF)

1 – 25 von 1.375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.161)
Mit Volltextzugriff
(1.223)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(826)
Life Sciences & Biomedicine
(701)
Humans
(500)
Female
(297)
Male
(271)
Adult
(180)
Middle Aged
(174)
Animals
(161)
Biological And Medical Sciences
(145)
Aged
(123)
Life Sciences
(118)
Medical Sciences
(116)
Mice
(77)
Adolescent
(72)
Neurosciences & Neurology
(70)
Patients
(70)
Oncology
(69)
Biochemistry & Molecular Biology
(68)
Child
(65)
Science & Technology - Other Topics
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(22)
Blood
(17)
The Journal Of Biological Chemistry
(16)
Circulation
(15)
Journal Of Clinical Oncology
(15)
Journal Of Biological Chemistry/the journal Of Biological Chemistry
(12)
Cancer Research
(11)
Nature Communications
(11)
Contact Dermatitis
(10)
Journal Of Hepatology
(9)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissues

Questioning behaviours and patterns of prospective teachers on practicum

Cancer-of-Unknown-Primary-Origin: A SEER–Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice

Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe

Critical Humanities and Ageing: Forging Interdisciplinary Dialogues

An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples

Die Bedeutung von Biobanken für die klinische Entwicklung

Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes

Modified study designs to expand treatment options in personalised oncology: a multistakeholder view

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience

Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States: A contemporary clinical practice patterns study

Does Organized Crime Attract EU Funding? Evidence from Sicily

Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)[S]

The significance of biobanks for clinical development

First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors

Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity

Addressing the dichotomy between individual and societal approaches to personalised medicine in oncology

Suchergebnisse filtern